Protein Description

Gene Symbol PGR
Entrez ID 5241
Uniprot ID P06401
Description progesterone receptor
Chromosomal Location chr11: 101,029,624-101,130,524
Ontology GO ID GO Term Definition Evidence

BP

GO:0006367

transcription initiation from RNA polymerase II promoter

Any process involved in the assembly of the RNA polymerase II preinitiation complex (PIC) at an RNA polymerase II promoter region of a DNA template, resulting in the subsequent synthesis of RNA from that promoter. The initiation phase includes PIC assembly and the formation of the first few bonds in the RNA chain, including abortive initiation, which occurs when the first few nucleotides are repeatedly synthesized and then released. Promoter clearance, or release, is the transition between the initiation and elongation phases of transcription.

TAS

BP

GO:0007165

signal transduction

The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.

TAS

BP

GO:0007267

cell-cell signaling

Any process that mediates the transfer of information from one cell to another. This process includes signal transduction in the receiving cell and, where applicable, release of a ligand and any processes that actively facilitate its transport and presentation to the receiving cell. Examples include signaling via soluble ligands, via cell adhesion molecules and via gap junctions.

TAS

BP

GO:0010629

negative regulation of gene expression

Any process that decreases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA (for protein-coding genes) and the translation of that mRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.

IEP

BP

GO:0043401

steroid hormone mediated signaling pathway

A series of molecular signals mediated by a steroid hormone binding to a receptor.

IEA

BP

GO:0045944

positive regulation of transcription from RNA polymerase II promoter

Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.

IDA

CC

GO:0005654

nucleoplasm

That part of the nuclear content other than the chromosomes or the nucleolus.

TAS

CC

GO:0005741

mitochondrial outer membrane

The outer, i.e. cytoplasm-facing, lipid bilayer of the mitochondrial envelope.

IEA

MF

GO:0000978

RNA polymerase II core promoter proximal region sequence-specific DNA binding

Interacting selectively and non-covalently with a sequence of DNA that is in cis with and relatively close to a core promoter for RNA polymerase II.

IDA

MF

GO:0001077

transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding

Interacting selectively and non-covalently with a sequence of DNA that is in cis with and relatively close to a core promoter for RNA polymerase II (RNAP II) in order to activate or increase the frequency, rate or extent of transcription from the RNAP II promoter.

IDA

MF

GO:0003677

DNA binding

Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid).

TAS

MF

GO:0003707

steroid hormone receptor activity

Combining with a steroid hormone and transmitting the signal within the cell to initiate a change in cell activity or function.

IEA

MF

GO:0005496

steroid binding

Interacting selectively and non-covalently with a steroid, any of a large group of substances that have in common a ring system based on 1,2-cyclopentanoperhydrophenanthrene.

IEA

MF

GO:0005515

protein binding

Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).

IPI

MF

GO:0008270

zinc ion binding

Interacting selectively and non-covalently with zinc (Zn) ions.

IEA

MF

GO:0019899

enzyme binding

Interacting selectively and non-covalently with any enzyme.

IPI

MF

GO:0051117

ATPase binding

Interacting selectively and non-covalently with an ATPase, any enzyme that catalyzes the hydrolysis of ATP.

IDA

Domain ID Description

IPR000128

Progesterone receptor

IPR000536

Nuclear hormone receptor, ligand-binding domain

IPR001628

Zinc finger, nuclear hormone receptor-type

IPR001723

Nuclear hormone receptor

IPR013088

Zinc finger, NHR/GATA-type

Pathway ID Pathway Term Pathway Source

hsa04114

Oocyte meiosis

KEGG

hsa04914

Progesterone-mediated oocyte maturation

KEGG

hsa05224

Breast cancer

KEGG

WP34

Ovarian Infertility Genes

WikiPathways

WP170

Nuclear Receptors

WikiPathways

h_mPRPathway

How Progesterone Initiates the Oocyte Maturation

BioCarta

UMLS CUI UMLS Term

C0001418

Adenocarcinoma

C0014170

Endometrial Neoplasms

C0014175

Endometriosis

C0024667

Animal Mammary Neoplasms

C0024668

Mammary Neoplasms, Experimental

C0025286

Meningioma

C0025500

Mesothelioma

C1458155

Mammary Neoplasms

Tissue Cell Type

cervix, uterine

glandular cells

endometrium

glandular cells

endometrium

cells in endometrial stroma

fallopian tube

glandular cells

smooth muscle

smooth muscle cells

Database Name

DisGeNET

Pubmed ID Author Year Title

22617121

Ouandaogo et al.

2012

Differences in transcriptomic profiles of human cumulus cells isolated from oocytes at GV, MI and MII stages after in vivo andin vitro oocyte maturation

22951915

Haozi et al.

2012

Altered gene expression profile in cumulus cells of mature MII oocytes from patients with polycystic ovary syndrome

Gene Symbol Entrez ID Uniprot ID Score

ZBTB17

7709

Q13105

0.52

ERBB2

2064

P04626

0.55

PIAS1

8554

O75925

0.55

PIAS3

10401

Q9Y6X2

0.55

SMARCE1

6605

Q969G3

0.56

ARID1A

8289

O14497

0.56

TRIM24

8805

O15164

0.59

RBM39

9584

Q14498

0.59

RBM23

55147

Q86U06

0.59

PARP1

142

P09874

0.63

BPTF

2186

Q12830

0.63

FKBP4

2288

Q02790

0.63

PPP5C

5536

P53041

0.63

MAPK1

5594

P28482

0.63

STAT5A

6776

P42229

0.63

STAT5B

6777

P51692

0.63

DNAJC7

7266

Q99615

0.63

PRDM2

7799

Q13029

0.63

SPOP

8405

O43791

0.63

STUB1

10273

Q9UNE7

0.63

NCOA2

10499

Q15596

0.63

SORBS1

10580

Q9BX66

0.65

SNW1

22938

Q13573

0.65

APEX2

27301

Q9UBZ4

0.65

COPS5

10987

Q92905

0.68

XRCC6

2547

P12956

0.70

XRCC5

7520

P13010

0.70

CDC25B

994

P30305

0.75

HMGB1

3146

P09429

0.75

HMGB2

3148

P26583

0.75

POU2F1

5451

P14859

0.75

RELA

5970

Q04206

0.75

SRC

6714

P12931

0.76

UBR5

51366

O95071

0.76

KLF9

687

Q13886

0.77

KAT2B

8850

Q92831

0.78

CUEDC2

79004

Q9H467

0.79

BATF3

55509

Q9NR55

0.80

CDK2

1017

P24941

0.82

FKBP5

2289

Q13451

0.84

SP1

6667

P08047

0.84

ESR1

2099

P03372

0.85

NCOA1

8648

Q15788

0.86

PGR

5241

P06401

0.87

UBE3A

7337

Q05086

0.88

NCOA3

8202

Q9Y6Q9

0.89

JDP2

122953

Q8WYK2

0.89

HSP90AA1

3320

P07900

0.49

CSNK2A1

1457

P68400

0.52

CCNA2

890

P20248

0.55

ANP32A

8125

P39687

0.56

TAF1B

9014

Q53T94

0.56

PRMT2

3275

P55345

0.59

BCAS2

10286

O75934

0.59

EP300

2033

Q09472

0.63

FGFR2

2263

P21802

0.63

GNAI1

2770

P63096

0.63

RNF4

6047

P78317

0.63

SGTA

6449

O43765

0.63

SMARCA1

6594

P28370

0.63

NCOR1

9611

O75376

0.63

PRKDC

5591

P78527

0.65

NR0B1

190

P51843

0.68

CCNA1

8900

P78396

0.72

MAGEA11

4110

P43364

0.73

POU2F2

5452

P09086

0.75

SMARCD1

6602

Q96GM5

0.75

TDG

6996

Q13569

0.75

DAP3

7818

P51398

0.75

PIAS2

9063

O75928

0.75

DDX54

79039

Q8TDD1

0.75

BRCA1

672

P38398

0.80

STAT3

6774

P40763

0.84

NCOR2

9612

Q9Y618

0.90